Pharma Industry Insights & Resources

Gene and cell therapy webinar

In this webinar, Pfizer scientists share their unique insights into how process, methods, and platform factors light the way for success, driving optimized yields, accelerated timelines to market, and more reliable process and manufacturing outcomes.

Gene and cell therapy

A CDMO with years of experience is crucial when producing life-changing gene and cell therapies, so choosing the right partner is key. Our experts are here to help you navigate the path to market, for your gene and cell therapy.

With a team comprising over 70 expert gene and cell therapy scientists, we leverage many years of working in this space to build and optimize our gene and cell therapy platform.

Download our brochure to see how we can bring your breakthrough to light

What to look for in a gene and cell therapy CDMO partner

Gene and cell therapies (GCTs) are offering life-changing new treatment options for genetic disorders. Our eBook examines the critical aspects of the development and manufacturing of GCTs and how we can help bring these therapeutics from clinical stages to commercialization.

Gene and cell therapy analytical and development methods: A path to success

Process development and analytical development are integral parts of gene therapy manufacturing. This whitepaper explores the analytical and development approaches needed to create a path to success in the clinic and beyond.

What Trends Will Shape the Pharma and Biotech Industries in 2023?

From adapting to budget constraints to weathering ongoing supply chain challenges, our industry experts discuss the forces that are driving current changes across the pharma and biotech sectors and share their insights into what we can expect in the market in 2023.

What Makes Us Altogether Different

For over 40 years, we've been listening, solving, and guiding our partners' drug projects to success. But what makes us an altogether different kind of CDMO to work with? Find out here.

Customer spotlight: Scaling success through strategic partnerships

The development of life-changing drugs is crucial to improving patient health and well-being. However, there are many difficulties drug developers face on the journey from laboratory discovery to widespread patient access, including when it comes to scaling up drug manufacturing.

Customer insight: Scaling success through strategic partnerships

Making the complex. Simple.

Let our informative infographic explain exactly what makes us a leading CDMO — ready to meet your complex oral solid dose needs seamlessly and simply.

Overcoming supply chain roadblocks to enable reliable complex OSD delivery at Pfizer CentreOne, Ascoli.

In our in-depth case study, the experts at Pfizer CentreOne explore the importance of effective communication and flawless supply chain management in the face of some unique technical hurdles.

Pfizer CentreOne: Ready to meet your complex OSD needs, seamlessly and simply.

To meet the demands of the oral solid dosage (OSD) market, new techniques and technologies have emerged.

Assuring drug substance and product supply chains to support worldwide delivery of Sobi’s life-saving biologic

Sobi, a specialized international biopharmaceutical company transforming the lives of people with rare and debilitating diseases observed an unpredicted increase in demand.

Harmonization in process development science

In this blog, Bernd Schümmelfeder, Director-Team Leader PPD Business Development at Pfizer, explores how process development — just like creating beautiful music — relies on collaboration between all involved.